The Wellness Institute - La Jolla

The Wellness Institute in La Jolla, California operates under the clinical direction of Henry Elloso, an Academy of Orthopedic Physical Therapy (AOPP) practitioner and MagnaWave Certified Practitioner who integrates regenerative medicine protocols with advanced pain management techniques. The clinic's location in La Jolla provides access to patients throughout San Diego County seeking alternatives to conventional pain management and age-related decline interventions. Elloso's dual certification in orthopedic physical therapy and pulsed electromagnetic field therapy (PEMF) through MagnaWave creates a treatment framework that combines peptide-based cellular regeneration with non-invasive energy medicine modalities.

NAD+ (nicotinamide adenine dinucleotide) therapy forms the cornerstone of the clinic's peptide offerings, administered through intravenous protocols designed to restore cellular energy production at the mitochondrial level. The clinic's NAD+ infusions target age-related NAD+ depletion, which research links to declining mitochondrial function, impaired DNA repair mechanisms, and reduced sirtuin enzyme activity. Treatment protocols at The Wellness Institute typically involve multi-hour IV sessions with dosing customized to individual patient metabolic profiles and treatment goals, whether addressing chronic fatigue, cognitive decline, metabolic dysfunction, or supporting recovery from substance dependence. The integration of NAD+ therapy with the clinic's IV nutrition protocols allows for concurrent delivery of methylated B-vitamins, amino acids, and antioxidants that support the NAD+ metabolic pathway and enhance cellular uptake.

Elloso's background in orthopedic physical therapy informs the clinic's approach to pain management, particularly for patients with musculoskeletal conditions, sports injuries, and chronic pain syndromes that have not responded adequately to conventional physical therapy or pharmaceutical interventions. The combination of MagnaWave PEMF therapy with regenerative peptide protocols creates a treatment model addressing both acute tissue repair and long-term cellular regeneration. Patients with conditions including osteoarthritis, tendinopathies, post-surgical recovery needs, and neuropathic pain conditions receive individualized treatment plans that may incorporate NAD+ for systemic cellular support alongside targeted PEMF applications to affected tissues.

The in-person consultation model at The Wellness Institute in La Jolla requires patients to visit the clinic for initial assessment and ongoing treatment sessions, with Elloso conducting comprehensive evaluations that include movement analysis, pain pattern assessment, and metabolic health screening to determine candidacy for NAD+ and other regenerative protocols. New patients undergo detailed intake procedures examining medical history, current medications, previous treatment responses, and specific wellness or pain management goals. The clinic's 5.0-star rating across 13 Google reviews reflects patient experiences with the personalized attention provided during multi-hour NAD+ infusion sessions and the clinical environment Elloso has established for patients undergoing regenerative treatments.

The Wellness Institute differentiates itself in the La Jolla regenerative medicine landscape through Elloso's integration of AOPP-informed musculoskeletal expertise with cellular-level interventions, creating treatment pathways for patients seeking alternatives to surgical interventions or long-term pharmaceutical pain management. The clinic's focus on NAD+ as a primary peptide therapy reflects a specialized approach rather than offering extensive peptide menus, allowing for deep clinical experience with NAD+ protocols across diverse patient populations. Patients from throughout San Diego County access the La Jolla location for treatments combining the immediate tissue-level effects of PEMF therapy with the systemic cellular regeneration supported by NAD+ infusions, creating a regenerative medicine model that addresses both symptomatic relief and underlying cellular dysfunction.